These improvements in glucose control are associated with reduced risk of long-term complications including cardiovascular disease, neuropathy, and nephropathy
A recent clinical trial found that semaglutide (Ozempic/Wegovy) was associated with a substantial reduction in heavy alcohol consumption among individuals with alcohol use disorder (AUD) and obesity, while also supporting weight loss
Medical availability disclaimer: Information about a peptide on this page does not guarantee that it is currently available, appropriate or legally dispensable in your location
Clinics that operate under a strong medical leadership team will not only prescribe but also proactively monitor changes in your weight, vitals, and lab work
Moreover, the side effects of these medications can be severe: pancreatitis, bowel obstruction, gastroparesis, nausea & vomiting, diarrhea as well as dietary insufficiencies
Therefore, identifying an optimized receptor potency ratio is crucial to harmonize efficacy and safety
